Revascularization Options for Left Main Disease: What Clinicians Need to Know

Curr Atheroscler Rep. 2023 Jun;25(6):267-273. doi: 10.1007/s11883-023-01105-2. Epub 2023 May 13.

Abstract

Purpose of review: Left main disease represents the highest-risk lesion subset of coronary artery disease and is associated with adverse cardiovascular events. Accordingly, we aim to understand how the significance of left main disease is assessed by different modalities, followed by a review of management options in current era.

Recent findings: Invasive coronary angiogram remains the gold standard for assessment of left main disease, but intracoronary imaging or physiological testing is indicated for angiographically equivocal disease. Revascularization by either coronary artery bypass surgery or percutaneous coronary intervention is strongly recommended, which have been compared by six randomized trials, as well as recent meta-analyses. Surgical revascularization remains the preferred mode of revascularization, especially in patients with high lesion complexity and left ventricular dysfunction. Randomized studies are needed to understand if current-generation stents with the use of intracoronary imaging and improved medical therapy could match outcomes with surgical revascularization.

Keywords: Coronary artery bypass; Coronary artery disease; Diabetes mellitus; Intravascular ultrasonography; Left ventricular dysfunction; Percutaneous coronary intervention.

Publication types

  • Review

MeSH terms

  • Coronary Angiography
  • Coronary Artery Bypass / adverse effects
  • Coronary Artery Disease* / complications
  • Coronary Artery Disease* / diagnosis
  • Coronary Artery Disease* / surgery
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Treatment Outcome